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Our understanding of the signalling pathways regulating early human development is limited,
despite their fundamental biological importance. Here, we mine transcriptomics datasets to
investigate signalling in the human embryo and identify expression for the insulin and insulin
growth factor 1 (IGF1) receptors, along with IGF1 ligand. Consequently, we generate a minimal
chemically-defined culture medium in which IGF1 together with Activin maintain self-renewal
in the absence of fibroblast growth factor (FGF) signalling. Under these conditions, we derive
several pluripotent stem cell lines that express pluripotency-associated genes, retain high
viability and a normal karyotype, and can be genetically modified or differentiated into
multiple cell lineages. We also identify active phosphoinositide 3-kinase (PI3K)/AKT/mTOR
signalling in early human embryos, and in both primed and naïve pluripotent culture condi-
tions. This demonstrates that signalling insights from human blastocysts can be used to
define culture conditions that more closely recapitulate the embryonic niche.
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Understanding the signalling pathways driving early lineagespecification in mouse preimplantation embryos hasinformed the establishment of both mouse embryonic and
extraembryonic stem cell lines. For example, fibroblast growth
factor (FGF) signalling and consequent mitogen-activated protein
kinase (MAPK) pathway activation in the inner cell mass (ICM)
regulates the divergence of pluripotent epiblast (EPI) and extra-
embryonic primitive endoderm (PE) cells, that will eventually
give rise to the embryo proper and yolk sac, respectively1. Inhi-
biting FGF/MAPK signalling during mouse embryo culture
increases the proportion of NANOG-expressing cells within the
ICM, while treatment with FGF ligands results in conversion of
ICM cells to GATA6-positive PE progenitors2,3. In addition,
leukaemia inhibitor factor (LIF) is associated with diapause, the
delayed implantation of mouse preimplantation embryos4.
Consistent with the mouse embryo, pluripotent mouse
embryonic stem cells (mESCs) can be cultured in medium sup-
plemented with LIF and inhibitors of FGF/MAPK signaling5,6.
Addition of MEK and GSK3β inhibitors together with LIF allows
mESCs to be propagated in defined medium (2i+ LIF) in the
absence of BMP, serum or a mouse embryonic fibroblast (MEF)
supportive layer2,7. Conversely, culture with FGF4-supplemented
medium supports the successful derivation of trophoblast stem
cells from the mouse TE, and extraembryonic endoderm cells
from the PE8,9.
In contrast, only a few studies have interrogated the signalling
pathways that contribute to the regulation of early human
embryo cell types. TGFβ/Nodal signalling is active during early
human development and has been implicated in maintaining
NANOG expression in the human EPI10, as well as regulating
pluripotency gene expression in human embryonic stem cells
(hESCs)11–15. Intriguingly, in contrast to the mouse, there does
not appear to be a role for FGF signalling in the divergence of EPI
and PE lineages in human embryos16,17. Inhibiting FGF receptors
or MEK has no obvious effect on pluripotency gene expression in
the human EPI16,17. However, FGF2 is routinely used to maintain
hESCs, having initially emerged as a putative pathway of interest
in experiments aiming to clonally culture hESCs18. The addition
of FGF2 ligand is thought to be required for continuous undif-
ferentiated proliferation in feeder-free media19–21. FGF is inclu-
ded in the majority of hESC culture medium, either by the
addition of exogenous ligand, or by co-culture with mitotically
inactivated fibroblast (MEF) layers, use of MEF-conditioned
medium, or growth on a Matrigel matrix22–27.
However, recently established alternative hESC culture condi-
tions that more closely resemble those used to propagate naïve
mESCs28–34, rely on MEK inhibition together with other signal-
ling inhibitors to maintain hESCs. While this suggests that MEK/
ERK signalling may be dispensable for hESCs, these conditions
rarely fully remove FGF supplementation. It is therefore unclear
whether FGF signalling may still be functioning independently of
MEK/ERK in this context. It has also been suggested that FGF
addition only indirectly promotes hESC pluripotency, instead
stimulating either the supportive MEF layer35, or fibroblast-like
cells differentiated from hESCs themselves36, to secrete factors
that subsequently promote proliferation.
We set out to investigate active signalling pathways in the
human EPI, reasoning that as in the mouse, identifying these
pathways in embryos would inform strategies for maintaining
pluripotent hESCs in physiologically relevant conditions. Here we
mine available datasets to identify receptor-ligand pairs present at
the transcriptional level, in order to determine if modulating
these pathways could promote either self-renewal or plur-
ipotency. We find that IGF1 ligand and the IGF1 and insulin
receptors are expressed in the human PE and EPI, respectively.
IGF1 supplementation together with Activin (AI medium)
supports hESC pluripotency in chemically defined conditions
without FGF addition or MEF co-culture. Under these conditions,
we derive hESCs from embryos, as well as induced pluripotent
stem cells (iPSCs) reprogrammed from fibroblasts. AI-cultured
hESCs exhibit a transcriptional expression profile similar to
hESCs cultured under conventional conditions, retain the ability
to differentiate into a variety of cell types, and can be genetically
modified using CRISPR/Cas9 mutagenesis. We identify active
IGF signalling via phosphoinositide 3-kinase (PI3K)/mTOR in
human preimplantation embryos, and in both conventional
and naïve hESC culture conditions, and determine that inhibiting
FGF receptors does not adversely affect hESC maintenance.
The successful generation of these pluripotent self-renewing cell
lines demonstrates the utility of our approach of integrating
signalling insights from the human early embryo to design
minimal FGF-free hESC culture conditions that better reflect the
pluripotent niche.
Results
IGF signalling components are expressed in the human epi-
blast. We interrogated published single-cell early human tran-
scriptome datasets10,37 to identify lineage-associated gene
expression patterns in the human blastocyst, comparing the
human pluripotent EPI to the extraembryonic TE and the PE. We
previously showed that several TGFβ/NODAL signalling-
associated genes were enriched in the EPI, and that intact
TGFβ/Nodal signalling is required for pluripotency gene
expression in the human embryo10, as had been described in
hESCs13. We therefore reasoned that our transcriptome datasets
could identify signalling pathways in the human embryo that
might have relevance for the establishment or maintenance
of hESCs.
To identify EPI, PE or TE-associated signalling networks, we
performed a comparative gene set enrichment analysis (GSEA)38
and visualised pathway relationships using the EnrichmentMap
tool39 in Cytoscape40 (Supplementary Fig. 1, Supplementary
Data 1). We overlaid gene expression, represented as boxplots,
onto KEGG pathway maps41 thereby creating a searchable visual
representation of expression for each pathway component in each
cell lineage (https://shiny.crick.ac.uk/embryo_signalling/). To
identify ligand and cognate receptor pairs that might suggest
signalling pathways to modulate, we curated a list of ligands and
receptors from all signal transduction pathways in the KEGG
database, and integrated protein-protein interactions using the
HIPPIE database42 (Supplementary Data 2). This represents a
comprehensive analysis of signalling pathway-associated tran-
scripts that are expressed in human preimplantation embryos at a
time when three distinct cell types are becoming specified in their
fate and function.
As in our previous study10, our analysis indicated that
pathways associated with TGFβ/NODAL signalling were enriched
in the EPI compared to the TE. Furthermore, pathways related to
regulation of IGF activity, JAK/STAT signalling and interleukin
signalling were enriched in the EPI and PE compared to the TE
(Supplementary Data 1). Transcripts for the insulin (INSR) and
IGF1 (IGF1R) receptors were more highly enriched in the EPI,
while insulin-like growth factor 1 (IGF1) ligand was enriched in
the PE (Fig. 1a). The interleukin 6 receptor subunit (IL6R), which
can colocalise with IGF receptors to induce Akt-mediated
proliferation in alternative contexts43,44, was also enriched in
the EPI (Supplementary Data 1). IL-6 activity has been shown to
regulate downstream JAK/STATs45 and to crosstalk with insulin/
IGF143. The type II diabetes pathway was also identified as
enriched in the EPI; this includes genes encoding insulin and IGF
receptors as well as downstream PI3K signalling effectors
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(Supplementary Data 1), and further suggested that modulating
IGF signalling would be of interest.
Enrichment analysis showed that genes related to negative
regulation of FGFR signalling were present in the EPI, which
could reflect negative feedback loops indicating pathway activa-
tion (Supplementary Data 1). However, we did not find FGF-
related receptors specifically highly enriched in the EPI. Boxplot
analysis showed FGFR1, FGFR2 and FGFR4 were more highly
expressed in the PE, while transcripts for FGF ligands, with
the exception of FGF18, were not expressed above the required
5 RPKM threshold (Supplementary Fig. 3). The expression of
downstream MAPK pathway components (e.g. KRAS and
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MAPK1) suggests that Receptor Tyrosine Kinase (RTK) signalling
may be activated by alternative receptors or via signalling
pathway cross-talk.
Given the enrichment of IGF/insulin signalling-related com-
ponents, we set out to develop a minimal hESC culture medium
using TGFβ/Nodal, with IGF in place of FGF. As the expression
of insulin, IGF2 and IGF2R transcripts were either undetectable
or not specifically expressed in EPI cells (Fig. 1a), we chose to
proceed using IGF1 ligand.
A chemically defined minimal hESC medium comprising
Activin and IGF1. We first sought to select an appropriate
basement membrane substrate for hESC maintenance, inter-
rogating the transcriptome dataset to identify enriched known
integrin binding partners of commonly used basement mem-
brane proteins46,47. Transcripts for laminin-binding Integrin-
α6β1 (ITGA6, ITGB1) were expressed in the human EPI, as well
as the TE and PE (Supplementary Fig. 4a). However, integrin
subunits integrin-α5 (ITGA5) and integrin-αV (ITGAV), which
complex with ITGB1 as Integrin-α5β1 and Integrin-αVβ1 to
bind fibronectin and vitronectin respectively, were not detected
in the EPI (Supplementary Fig. 4a). This suggests that plur-
ipotent cells in vivo may be specifically receptive to laminins.
We adapted hESCs to either whole recombinant human
laminin-51148 or a recombinant laminin-511 E8 fragment49,50,
and found that, as in previous studies, these maintained hESC
morphology comparable to those on Matrigel (Supplementary
Fig. 4b). We therefore continued with this embryo-specific
basement membrane component for hESC culture in chemically
defined conditions.
We next sought to establish a viable culture system using IGF1
and Activin. hESCs were grown on laminin-511 in either control
mTeSR1 medium, or adapted to basal medium alone (Advanced-
DMEM/F12 plus 2 mM glutamine supplement); basal medium
plus 10 ng/ml Activin and 12 ng/ml FGF2 (previously published
growth factor concentrations12); basal medium plus 17 nM IGF1
(concentration based on calculations from human uterine fluid51)
or basal medium plus 10 ng/ml Activin and 17 nM IGF1
(Supplementary Fig. 4c). hESCs cultured in basal medium plus
Activin and IGF1 (hereafter AI medium) resembled control cells
in mTeSR1 or Knockout serum replacement (KSR) and FGF2
(KSR+ FGF2) media, with tightly packed colonies and distinct
colony boundaries (Fig. 1b, Supplementary Fig. 4c). hESCs in AI
medium could be propagated by passaging in clumps via manual
picking or using Ca+/Mg+-free PBS, Gentle Cell Dissociation
Buffer or ReLeSR reagents, but not EDTA (Supplementary Fig. 4d).
Single cells could also be disaggregated with Accumax in the
presence of a Rho-associated kinase (ROCK) inhibitor, and then
further propagated equivalent to those passaged as clumps
(Supplementary Fig. 4e).
Independent hESCs (H1, H9, Shef6) and iPSCs (RCiB10)
adapted to AI medium have been propagated for multiple
passages, including lines that have been maintained for over
24 months and over 70 passages. Cells were passaged on an
approximate 4 to 5-day cycle using Accumax single-cell
dissociation with ROCK inhibitor and retained a high nuclear-
to-cytoplasmic ratio (Supplementary Fig. 4e). Immunofluores-
cence and flow cytometry analysis determined that hESCs and
iPSCs adapted to AI medium robustly expressed pluripotency-
associated factors NANOG, OCT4 and SOX2, and the cell surface
antigens TRA-1-60, SSEA4, CD30 and SSEA3, in proportions
comparable to hESCs cultured in mTeSR1 or KSR+ FGF2
(Fig. 1c, d, Supplementary Fig. 5a, b). This was maintained
whether cells were passaged as single cells or in clumps,
suggesting AI medium could also support the establishment of
clonal cell lines and the derivation of transgenic or genetically
modified hESCs. To test this, we nucleofected hESCs cultured in
AI medium with a plasmid engineered to express the Cas9 gene
and a guide RNA targeting a non-essential gene in hESCs
(ARGFX) plus a puromycin selection cassette. After 48 h of
puromycin selection and subsequent clonal expansion for 10 days,
colonies were confirmed to be positive for alkaline phosphatase
(Supplementary Fig. 5c). A T7 endonuclease assay confirmed that
the hESCs cultured in AI medium had been successfully targeted
(Supplementary Fig. 5d).
G-band karyotype analysis and whole-genome sequencing
confirmed that both hESCs and iPSCs cultured in AI medium for
multiple passages retained a normal complement of 46 chromo-
somes (Supplementary Fig. 5e–g). AI-cultured hESCs and iPSCs
retained high viability and proliferated similar to cells cultured in
mTeSR1 or KSR+ FGF2 (Supplementary Fig. 5h). Altogether,
these data illustrate that a minimal medium comprising Activin
and IGF1 (AI) is sufficient to support pluripotent cell cultures.
AI medium supports de novo hESC-derivation and iPSC
reprogramming. We next asked whether AI medium could be
used to derive hESCs from human embryos. Blastocysts were
cultured overnight in human embryo culture medium. The ICM
and overlaying polar TE were then microdissected from the mural
TE, and plated in AI medium on MEFs (Fig. 1e). hESC-like
colonies emerged within a week of plating and were maintained
thereafter as stable hESC lines on laminin-511 (Fig. 1e). Immu-
nofluorescence and flow cytometry analysis confirmed that AI-
derived hESCs expressed pluripotency-associated intracellular
Fig. 1 A chemically defined hESC medium comprising Activin and IGF. a Boxplots of RPKM values for insulin (INS) and IGF ligands (IGF1, IGF2), and
cognate receptors in human blastocyst lineages (EPI green, PE red, TE blue) determined by single-cell RNA-seq10. Boxes symbolise first and third quartiles,
horizontal lines the median, whiskers extend to 1.5 times the interquartile range, dots represent outliers. b Representative phase-contrast images of hESCs
in KSR+ FGF2 on MEFs, or mTeSR1 or AI medium on laminin-511. n= 2 or 3 biological and 3 technical replicates. Scale bar: 300 μm, top row; 200 μm
bottom row. c Flow cytometry of AI-adapted Shef6 hESCs for the indicated proteins (blue); isotype control in grey. n= 3 technical replicates.
d Representative immunofluorescence of AI-adapted Shef6 hESCs for the indicated proteins; DAPI (blue) nuclear stain. n= 3 biological replicates. Scale
bar: 100 μm. e Upper panels: Representative image of a human day 6 blastocyst prior to ICM (circled) dissection and plating in AI medium on MEFs. The
resulting ICM outgrowth (circled) was passaged onto laminin-511 to establish a stable hESC cell line (CH2). Scale bar: 150 μm. n= 3 biological replicates.
Lower panels: Representative images of iPSCs derived following reprogramming of BJ fibroblasts with Sendai viruses. iPSC-like colonies (circled) could be
detected in AI medium within 12 days of induction, and expanded for picking within 18 days to propagate an established iPSC line (CHiP1). n= 2 technical
replicates. Scale bars, left to right: 300 μm, 100 μm, 100 μm. f–h Representative immunofluorescence of AI-cultured hESCs following directed
differentiation. n= 3 biological replicates. DAPI in blue. f hESCs differentiated towards hepatocyte-like cells first express endoderm markers CXCR4
(green) and SOX17 (red), upregulate FOXA2 (green) as foregut endoderm, then AFP (red) and CK18 (green) as hepatocytes. Scale bar: 100 μm.
g Expression of CTNT (green; scale bar 50 μm), α-Actin (green; scale bar 100 μm) and NKX2.5 (red; scale bar 100 μm) following directed differentiation
towards cardiomyocyte-like cells. h Expression of neuronal markers OTX2, PAX6, TUJ1 (green) and NESTIN (red) following directed differentiation towards
neuronal progenitor cells. Scale bar: 100 μm.
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and cell surface markers, and were comparable to H9 cells in
mTeSR1, KSR+ FGF2 or naïve t2iL+Gö conditions (Supple-
mentary Figs. 5i, 6). Three stable lines, CH1, CH2 and CH3 were
derived under AI conditions.
We also evaluated whether AI medium could support
derivation of iPSCs from human fibroblasts using two standard
reprogramming methods. In the first instance, we virally
transduced BJ new-born foreskin fibroblasts (ATCC®CRL-2522)
with Sendai virus vectors harbouring the reprogramming factors
OCT4, SOX2, KLF4 and c-MYC52. Following transduction,
fibroblast cells were re-plated into KSR+ FGF2, TeSR-E8 or AI
medium. Colonies resembling pluripotent stem cells emerged
within 12 days (Fig. 1e, Supplementary Fig. 5j, circled) and
expressed TRA-1-60, confirming their iPSC-like identity (Sup-
plementary Fig. 5k). Colonies in AI medium were confirmed to be
positive for alkaline phosphatase expression (Supplementary
Fig. 5l), continued to expand over time and were passaged with
Accutase to establish stable iPSC lines (Fig. 1e).
We also reprogrammed a second foetal lung fibroblast
cell line MRC5 (ECACC 05072101) with non-modified
RNAs53, using either AI or Nutristem® medium. Morphologi-
cal changes were observed from day 3 of the reprogramming
timeline, and by day 9, iPSC colonies were evident under both
conditions. Colonies were shown to be positive for alkaline
phosphatase activity on day 34 (Supplementary Fig. 5m), and
were further propagated on laminin-511 and passaged using
TrypLE™ Express (Supplementary Fig. 5n). Altogether, this
demonstrates that AI medium supports the establishment of
both self-renewing iPSC colonies and hESCs from human
embryos.
AI hESCs respond effectively to differentiation cues. We sought
to determine whether AI-adapted hESCs remained capable of
responding to directed differentiation cues. We first evaluated
their propensity to differentiate into hepatocyte-like cells, using a
standard protocol54. Immunofluorescence analysis confirmed
emergence of initial pan-endoderm cells expressing SOX17 and
CXCR4, followed by foregut endoderm cells expressing FOXA2,
and eventually hepatocyte-like cells expressing alpha-fetoprotein
(AFP) and cytokeratin-18 (CK18) (Fig. 1f).
We also differentiated AI-adapted hESCs into cardiomyocytes
using the STEMdiff cardiomyocyte differentiation kit. qRT-PCR
analysis confirmed upregulation of GATA4, ISL1, TBX5, MEF2C,
MLC2A and TNNT2 lineage markers, and downregulation of
NANOG, OCT4 and SOX2 as differentiation progressed (Supple-
mentary Fig. 7a). Differentiated cells displayed typical cardio-
myocyte morphology, growing as an adherent tightly packed
monolayer that contracted in culture (Supplementary Movie 1),
indicating they had acquired the potential for electrical activity.
Immunofluorescence analysis confirmed the expression of cardiac
muscle markers NKX2.5, α-Actin and cardiac troponin (CTNT)
(Fig. 1g).
Finally, we used a standard dual SMAD inhibition protocol to
generate neuronal progenitor cells from AI-adapted hESCs55. We
detected the expression of OTX2, PAX6, NESTIN and TUJ1 by
immunofluorescence, confirming the neuronal identity of the
differentiated cells (Fig. 1h).
In addition, AI-derived hESCs were allowed to spontaneously
differentiate by culturing in MEF medium for up to 2 weeks.
Immunofluorescence analysis confirmed the emergence of
SOX17-expressing endoderm cells, TUJ1-expressing ectoder-
mally-derived neurons and DESMIN-expressing mesoderm cells
(Supplementary Fig. 7b). Altogether, we confirmed that AI-
cultured hESCs retained the capacity to differentiate into multiple
cell lineages.
AI hESCs are transcriptionally similar to conventional hESCs.
We next compared the transcriptome of individual AI-cultured
hESCs to published single-cell datasets from human blastocyst
embryos10,37,56. As a comparison, we also included hESCs cul-
tured in conventional KSR+ FGF2 on MEFs or mTeSR1 media
on either Matrigel or laminin-511.
After adjusting for batch effects in the expression data, we used
3087 variably expressed genes to perform dimensionality
reduction analyses. Principal component analysis (PCA) indi-
cated that principal component 1 (PC1) separated hESCs and
blastocyst samples, while PC2 and PC3 distinguished hESCS in
AI and mTeSR1 from hESCs cultured in KSR+ FGF2 media
(Supplementary Fig. 8a). These patterns were confirmed using
uniform manifold approximation and projection57 (UMAP), a
non-linear dimensionality reduction method (Supplementary
Fig. 8b). Controlling for confounding sources of variance (e.g.
cell cycle) using the graph inference of population heterogeneity
(griph) clustering tool indicated that AI-cultured hESCs were
transcriptionally similar to mTeSR1-cultured hESCs, somewhat
distinct from cells in KSR+ FGF2, and comparatively distinct
from blastocyst cells (Supplementary Fig. 8c).
We next compared global gene expression of AI-cultured
hESCs to hESCs in naïve hESC culture medium by integrating
several published datasets2833,58. The griph clustering tool
indicated that the first dimension (Dim1) separated all hESCs
from the embryo EPI, PE and TE cells (Fig. 2a). In the second
dimension (Dim2), naïve hESCs clustered distinctly compared to
hESCs cultured in AI, mTeSR1 or KSR+ FGF media. We also
included a comparison to a cynomolgus monkey embryo
dataset59, where it was suggested that hESCs in conventional
conditions cluster more closely to the post-implantation cyno-
molgus monkey EPI, while those in naïve conditions are more
similar to the pre-implantation compartment. PCA and UMAP
analysis indicated that hESCs in AI and mTeSR1 clustered
together, while cynomolgus monkey ESCs and hESCs in naïve
conditions clustered with the post-implantation cynomolgus EPI
(Supplementary Fig. 8d). Both these groups were distinct from
the human EPI and cynomolgus pre-implantation EPI samples.
To further characterise each cell type, we performed pair-wise
differential gene expression analysis using DESeq2 to compare
hESCs cultured in AI medium, mTeSR1 on Matrigel or laminin-
511, KSR+ FGF2 or naïve hESC medium, with the embryonic
EPI, TE and PE cells (Supplementary Data 3). The genes most
differentially expressed were used to perform a GSEA using a
compendium of multiple signalling and pathway databases40
(Supplementary Data 4), as well as functional enrichment analysis
using Gene Ontology (GO)60 and REACTOME61 databases
(Fig. 2b, Supplementary Fig. 9a). Genes associated with extra-
cellular matrix organisation were enriched in AI-cultured hESCs,
consistent with the use of laminin basement membrane
components for adherent culture (Fig. 2b). Interestingly, genes
associated with the WNT signalling pathway were more highly
enriched in either AI- or mTeSR1-cultured hESCs on laminin
compared to the EPI (Supplementary Figs. 2b, 9b). Genes
associated with cholesterol biosynthetic processes were enriched
in mTeSR1-cultured hESCs on Matrigel compared to the EPI
(Supplementary Fig. 9c). In contrast to AI-cultured hESCs, the
EPI was enriched for genes associated with RNA binding and
transport, histone binding, translation initiation complex forma-
tion and activation of mRNA, suggesting differences in
transcription and translation. The EPI was also enriched for
genes associated with antiviral mechanisms, interferon-stimulated
genes and the immune system (Supplementary Data 4; Supple-
mentary Fig. 9a). Consistent with the PCA, UMAP and griph
analyses, mTeSR1-cultured hESCs on Matrigel or laminin-511
were transcriptionally similar to each other and differentially
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expressed genes were mostly associated with mitochondrial
function (Supplementary Data 5).
Functional enrichment analysis also highlighted that genes
associated with DNA methylation, histone deacetylases (HDACs),
RNA polymerase I promoter opening and nucleosome DNA
binding and assembly were more highly enriched in naïve hESCs
compared to the human EPI (Fig. 2c). This is consistent with the
distinct epigenetic state and global hypomethylation of naïve
hESCs33,62. By contrast, the genes more highly expressed in
human EPI cells were associated with mitochondrial function and
biogenesis as well as RNA polymerase activity and mRNA
splicing, suggesting differences in metabolism and transcriptional
regulation, compared to in vitro cultured naïve hESCs (Supple-
mentary Fig. 9d).
Consistent with previous publications63, we confirm that all
hESCs are transcriptionally distinct from EPI cells, irrespective of
the culture conditions, suggesting that further refinement of hESC
medium is needed to capture a more similar pluripotent state.
Altogether, the clustering analysis suggests that AI-cultured
hESCs are transcriptionally more similar to hESCs cultured in
conventional mTeSR1 or KSR+ FGF medium, than to hESCs
cultured in naïve conditions. This suggests that IGF1 and FGF2
may activate overlapping downstream mechanisms for the
maintenance of hESCs.
AI- or mTeSR1-cultured hESCs exhibit a similar X-chromosome
inactivation state. hESCs cultured in conventional versus naïve
culture conditions exhibit distinct X-inactivation states64. Con-
ventional primed female hESCs typically carry one active and one
inactive X-chromosome and the X-inactivation regulator XIST-
RNA coating is often absent65, while naïve cells reactivate the
inactive X-chromosome and exhibit mono-allelic XIST expres-
sion64. To characterise X-chromosome activity in AI-cultured
hESCs, we performed dual RNA fluorescence in situ hybridization
(RNA-FISH) for XIST and the X-linked gene ATRX. We compared
our findings with those observed in mTeSR1-cultured XX hESCs,
and in XXY fibroblasts (Fig. 2d). We observed mono-allelic
expression of ATRX and XIST in the majority of XXY fibroblasts,
consistent with the existence of X-inactivation. In the majority of
AI-cultured hESCs, ATRX was expressed mono-allelically, and
XIST clouds were absent. Similar findings were made in mTeSR1
hESCs, consistent with previous findings65. The X-inactivation
status of AI-cultured hESCs therefore resembles that of hESCs
cultured in more conventional conditions.
PI3K/mTOR signalling downstream of IGF1 regulates hESC
self-renewal. We next investigated mechanisms by which
IGF1 supports hESC self-renewal. Canonically, binding of insulin
or IGF ligands to their receptors results in phosphorylation and
activation of PI3K66 (Fig. 3a). PI3K phosphorylates the
membrane-bound phospholipid PIP2 to generate active PIP3,
which then activates a kinase cascade via phosphoinositide-
dependent kinase-1 (PDK1) and its substrates AKT and atypical
protein kinase Cs (aPKCs). Downstream AKT substrates include
mTOR, FOXO1, S6 and GSK3β66, and mTOR signalling has been
implicated in promoting hESC self-renewal and inhibiting
apoptosis67,68. Notably, these previous studies were performed in
hESC medium containing exogenous FGF, which can also acti-
vate PI3K downstream of FGF receptor binding69. Considering
the similarities between cells cultured in AI and mTeSR1 revealed
in our transcriptional analyses, we reasoned they might also
exhibit common signalling dynamics.
As expected, in AI-cultured hESCs we observed phosphoryla-
tion of the insulin and IGF1 receptors (IR and IGF1R), as well as
the downstream pathway components AKT-T308, AKT-S473
(pAKT) and S6 (pS6), confirming PI3K signalling pathway
activity (Fig. 3b). We also detected phosphorylated ERK1/2
(pERK), indicating active MAPK signalling (Fig. 3b), possibly as a
consequence of crosstalk between the PI3K and MAPK signalling
pathways. Both the IGF1R/insulin/PI3K and MAPK pathways
were also active in mTeSR1-cultured hESCs (Supplementary
Fig. 10a).
To determine whether AI-cultured cells were responsive to the
modulation of these pathways, we employed small molecule
inhibitors targeting various pathway components (Fig. 3b).
IGF1R/IR phosphorylation was reduced within 24 h of treatment
with the IGF1R/IR inhibitor OSI-906 (OSI), as was downstream
pAKT. Increased pERK was observed following OSI treatment,
suggesting crosstalk between the PI3K and MAPK signalling
pathways. Reduced pERK levels were observed within 24 h of
treatment with the FGF receptor tyrosine kinase inhibitor
PD173074 (PD17) or MEK inhibitor PD0325901 (PD03) (Fig. 3b).
Inhibition of mTOR with Everolimus led to the loss of
downstream pS6, as well as increased pAKT and pERK,
suggesting potential feedback to both of these pathways (Fig. 3b).
mTeSR1-cultured hESCs were similarly responsive to modulation
of these signalling pathway components (Supplementary
Fig. 10a).
We next treated AI- or mTeSR1-cultured hESCs with OSI,
Everolimus, PD17, or PD03 for 3 days to assess the impact on
proliferation over this time. Treatment with OSI or Everolimus
impacted both the morphology and proliferation of AI- or
mTeSR1-cultured hESCs (Fig. 3c, Supplementary Fig. 10b). PD03
treatment impacted proliferation in both culture media, suggest-
ing that MEK/ERK signalling is required for hESC self-renewal in
these conditions (Fig. 3c). However, treatment with PD17 had no
discernible effect on proliferation in either mTeSR1 or AI
medium (Fig. 3c) indicating that hESCs can be maintained
independent of FGF ligand availability. Although we observed
some downregulation of pERK following PD17 treatment,
suggesting FGFR kinase activity does feed into pERK in AI
conditions, this does not seem to be required for cell survival and
proliferation. The absence of any obvious loss of NANOG under
these inhibitor conditions (Fig. 3d) points to the specific role of
IGF1/insulin in regulating hESC proliferation.
We next sought to investigate the expression of these pathways
in naïve culture conditions, using hESCs in t2iL+Gö medium
(Supplementary Fig. 10c). pIGF1R/pIR, pAKT and pS6 were all
detectable in hESCs cultured in t2iL+Gö on Geltrex (Supple-
mentary Fig. 10d). Modulation with OSI, GDC or Everolimus
resulted in the inhibition of pIGFR1/pIR, pAKT or pS6
respectively, indicating that naïve cells are also responsive to
PI3K signalling modulation. Surprisingly, we detected pERK
expression in hESCs cultured in t2iL+Gö, despite the presence
of PD03 in these conditions (Supplementary Fig. 10d), suggesting
the concentration of PD03 used does not fully block MEK/ERK
signalling. Consistent with this, treatment with PD17 led to
downregulation of pERK, suggesting that MEK/ERK signalling
may still be active. Treatment of naïve cells with inhibitors for
3 days had no obvious impact on cell proliferation or NANOG
expression (Fig. 3c, d), although as long-term treatment has yet to
be assessed, there remains the possibility that prolonged inhibitor
treatment may impact self-renewal. Altogether our results
indicate that PI3K/mTOR signalling is active in both conven-
tional and naïve hESC culture conditions.
IGF1 regulates the proliferation of the human ICM. Given the
positive effect of IGF signalling on hESC proliferation and our
identification of PI3K/mTOR activity across hESC culture con-
ditions, we returned to the human embryo to interrogate the role
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of IGF1. Insulin/IGF1 signalling has been implicated in embryo
development, with studies suggesting that IGF1 may be present in
the fallopian tube and uterine fluid51,70. Studies treating human
embryos with IGF1 identified an increase in ICM cell numbers as
well as an increase in the proportion of embryos developing to the
blastocyst stage70,71. However, these studies did not investigate
pluripotency gene expression under these conditions.
We first investigated PI3K/mTOR signalling activity in human
embryos, developing a method based on a refined western blot
technique. Preliminary tests on mouse embryos were able to
reproducibly detect pAKT and pS6 expression from low numbers
of blastocysts (Fig. 4a). Human blastocysts were then collected at
7 days post fertilisation (dpf) and assayed, and we detected
phosphorylated AKT and S6 (Fig. 4a). Coupled with our initial
transcriptomics data showing IGF1 and insulin receptor enrich-
ment, this confirmed that IGF/PI3K signalling was likely to
function in human embryos. Given the cross-talk we observed
between downstream AKT/mTOR and MEK/ERK, we next
assayed pERK in mouse and human embryos and confirmed its
expression (Fig. 4a), suggesting activation of these pathways.
We next cultured four- to eight-cell human embryos at 2 dpf in
human embryo culture medium supplemented with 17 nM IGF1
(Fig. 4b). By 6.5 dpf, treated embryos had formed an expanded
blastocyst and expressed NANOG in the EPI, and the PE marker
SOX17, similar to controls (Fig. 4c). Embryos also expressed
KLF17 (Fig. 4d), a transcription factor we previously identified as
enriched in the EPI10. The automated software tool MINS 1.372
was used to detect and segment DAPI-stained nuclei to determine
embryo cell number. The ICM was identified by morphology, and
ICM cell number determined by tallying NANOG- or SOX17-
expressing cells. By 6.5 dpf the ICM proportion was increased in
IGF1-treated embryos compared to controls (Fig. 4e, P= 0.034,
one-tailed t-test). IGF1 treatment also resulted in a 2-fold increase
(P= 0.024) in the proportion of NANOG-expressing cells
(Fig. 4e). The proportions of SOX17-expressing cells were not
similarly affected (P= 0.083) and total embryo cell number was
equivalent to controls (Fig. 4e). In summary, IGF1 treatment has
a demonstrable proliferative effect in the ICM of the human
embryo.
As a comparison, we treated human embryos with exogenous
FGF. Although inhibiting FGF/ERK signalling in human
blastocysts does not impact pluripotency gene expression16,17,
FGF could perhaps promote ICM proliferation. Previous experi-
ments in the mouse showed that addition of 1 μg/ml FGF2 and 1
μg/ml heparin to embryo culture media resulted in a cell-fate
conversion of NANOG-expressing EPI cells to GATA6-
expressing PE cells by the blastocyst stage3. Therefore, in the
first instance a similar treatment schedule was applied to 4- to 8-
cell human embryos (2 dpf).
By 6.5 dpf, untreated control embryos formed an expanded
blastocyst and expressed both NANOG and GATA6 (Fig. 4f). In
contrast, FGF-treated embryos did not express NANOG and were
smaller compared to controls. This differs from FGF-treated
mouse embryos, which appear developmentally normal despite
lineage conversion within the ICM3. Embryos were next treated
with 100 ng/ml FGF2, a concentration commonly used to
maintain hESC pluripotency in vitro27. Again, by 6.5 dpf treated
embryos were smaller and lacked NANOG-expressing cells but
retained GATA6-expressing cells (Fig. 4f), indicating a negative
effect on pluripotency gene expression.
To determine if FGF stimulation affected established NANOG
expression, embryos were treated with 100 ng/ml FGF2 from 5
dpf, by which time NANOG expression is restricted to the ICM73.
Treated embryos appeared developmentally normal and NANOG
expression was maintained in the ICM (Fig. 4g). Analysis using
MINS 1.372 determined that proportions of both NANOG- and
SOX17-expressing cells and the total ICM were within the range
of controls (Fig. 4h; NANOG P= 0.150, SOX17 P= 0.348, ICM
P= 0.150). Altogether, this suggests that rather than operating via
an alternative pathway in the human embryo, FGF is unlikely to
be crucial for EPI development.
Discussion
The initial investigations that established conditions for hESC
derivation were carried out in non-human primates74, and these
have been transformative in enabling the establishment of hun-
dreds of hESC lines worldwide22. However, these conditions may
not necessarily reflect the requirements of early human
embryonic development. Several new culture systems have
recently been identified primarily via chemical screening methods
using existing stem cell lines28–34. We took an alternative
approach by analysing gene expression patterns and modulating
signalling in the human EPI directly, which we hypothesised
would help clarify the role of signalling in the embryo and elu-
cidate which pathways are recapitulated in in vitro derived hESC
lines. The signalling datasets we generated may inform further
refinement of hESC culture conditions, as well as optimisation of
human trophoblast75 and extraembryonic endoderm76 stem
cell media.
We show that IGF1 supplementation coupled with Activin
supports derivation and maintenance of human pluripotent stem
cells without the addition of exogenous FGF2. Interestingly,
despite displaying distinct morphology from mTeSR1-cultured
hESCs, AI hESCs were transcriptionally similar. This suggests
that scoring colonies based on morphology may not always
accurately reflect their transcriptional state, or self-renewal and
differentiation potential, consistent with previous findings77. AI
medium could also represent a simple yet refined alternative that
could be produced in any lab, in comparison to cost-prohibitive
commercial media. Importantly, the viability or proliferative
capacity of AI- or mTeSR1-cultured hESCs was unaffected by
FGF receptor inhibitors, in stark contrast to their requirement for
IGF1/insulin signalling, indicating IGF1/insulin signalling via
AKT/mTOR is necessary for hESC maintenance. Inhibiting MEK
impedes self-renewal in both AI and mTeSR1, indicating that a
mechanism involving this kinase plays a key role. However, it is
unclear whether ERK is involved, as pERK is also downregulated
following FGFR inhibition, where there is no effect on hESC
viability. Although ERK is commonly the master effector of the
MEK pathway, alternative substrates have been recently identi-
fied, such as heat-shock transcription factor 1 (HSF1)78. Fur-
thermore, while a few studies have implicated downstream
mTOR signalling components and FOXO proteins in the reg-
ulation of hESC viability and self-renewal68,79, additional study
will elucidate whether other downstream effectors may also be
required.
Interestingly, mTeSR1 medium contains insulin27, as do sev-
eral other hESC media, supplements and basement membrane
substrates27,80–84, suggesting this pathway is being stimulated to
support hESC self-renewal in existing culture conditions. Pre-
vious studies showed that inhibition of active PI3K/AKT signal-
ling in hESCs is required for differentiation85. IGF1 has also been
shown to confer an additional benefit in standard hESC medium
that contains exogenous FGF68,85,86. Adding an IGF1R-blocking
antibody to hESC cultures impeded the expansion of cells
expressing the pluripotency-associated marker SSEA3, which
could not be rescued by exogenous FGF2 supplementation36. A
combination of IGF1 and heregulin has also been shown to
reproduce the same positive effect on long-term hESC self-
renewal as high levels of FGF287. Notably, our conditions lack
heregulin, which is a member of the epidermal growth factor
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(EGF) family and thereby can activate the RTKs, similarly to
FGFs. While these studies suggested a cooperative role of FGF or
heregulin and IGF/insulin in maintaining hESCs, our inhibitor
experiments indicate that IGF/insulin signalling alone is
sufficient.
Intriguingly, however, the authors suggest that hESCs have
endogenous autocrine WNT signalling and that DKK1 (a WNT
signalling inhibitor) further promoted hESC self-renewal87.
Inhibiting WNT signalling also promotes naïve to primed hESC
transition88. Given our differential gene expression analysis
indicates WNT signalling differences in the EPI compared to AI-
cultured hESCs, this suggests that modulating WNT may also
promote hESC self-renewal. The expression of JAK/STAT and
NOTCH signalling components suggests that these pathways may
also be operational in human embryos, and determining the role
of these pathways may promote further refinement of human
pluripotent stem cell culture media. It would also be interesting to
determine if additional factors such as integrins contribute to
maintaining pluripotency, both in the developing embryo and in
hESCs. Although we find no major differences between AI-
cultured hESCs on laminin compared to mTeSR1-cultured hESCs
grown on either Matrigel or laminin, basement membrane sig-
nalling may be contributing to pluripotency maintenance in both
contexts. Adding integrin blocking antibodies or activating
b
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integrins to each culture medium would provide insight into this
question.
Altogether we demonstrate that taking an unbiased approach
to interrogate lineage-specific gene expression patterns directly in
the human blastocyst can be used to clarify the role of signalling
in the embryo, and shed light on which pathways can be reca-
pitulated in in vitro derived hESCs. Having defined a key sig-
nalling pathway required for the proliferation of early human
embryos and hESCs, our next goal is to elucidate the pathways
that regulate their pluripotency.
Methods
Ethics statement. Human embryos were donated to the research project by
informed consent under UK Human Fertilization and Embryo Authority (HFEA)
License number R0162. Approval was also obtained from the Health Research
Authority’s Cambridge Central Research Ethics Committee, IRAS project ID
200284 (Cambridge Central reference number 16/EE/0067). The approval process
entailed independent peer review along with approval from both the HFEA
Executive Licensing Panel and the Executive Committees. Our research is com-
pliant with the HFEA Code of Practice and has undergone independent HFEA
inspections since the license was granted. Patient consent was obtained from Bourn
Hall Clinic.
Informed consent was obtained from all couples that donated surplus embryos
following IVF treatment. Before giving consent, donors were provided with all of
the necessary information about the research project, an opportunity to receive
counselling, and details of the conditions that apply within the license and the
HFEA Code of Practice. Specifically, patients signed a consent form authorising the
use of their embryos for research including stem cell derivation and for the results
of these studies to be published in scientific journals. No financial inducements
were offered for donation. Patient information sheets and the consent documents
provided to patients are publicly available (https://www.crick.ac.uk/research/a-z-
researchers/researchers-k-o/kathy-niakan/hfea-licence/). Embryos were donated
cryopreserved and were transferred to the Francis Crick Institute where they were
thawed and used in the research project.
Human embryo culture. Vitrified embryos frozen in straws were thawed by
quickly transferring the contents of the straw from liquid nitrogen directly into
thaw solution (Irvine Scientific Vitrification Thaw Kit) and thawed per manu-
facturer’s instructions. Embryos frozen in cryopets were thawed for 3 seconds in a
37 °C water bath before transferring into thaw solution (Irvine Scientific Vitrifi-
cation Thaw Kit). Embryos frozen in glass ampoules were thawed completely in a
37 °C water bath after the top of the vial was removed under liquid nitrogen. The
contents were emptied onto a petri dish and the embryo transferred through a
gradient of sucrose solutions (Quinn’s Advantage Thaw Kit, Origio) per manu-
facturer’s instructions.
Embryos were routinely cultured in Global Media supplemented with 5 mg/mL
LifeGlobal Human Protein Supplement (both LifeGlobal) pre-equilibrated
overnight in an incubator at 37 °C and 5% CO2. For growth factor or inhibitor
treatment, these conditions were supplemented with IGF1 (291-G1/CF, R&D) at a
final concentration of 17 nM, or FGF2 (233-FB/CF, R&D) at a final concentration
of 100 ng/ml, or at 1 μg/ml with 1 μg/ml heparin.
Mouse embryo culture. All mice were treated with appropriate care according to
the ethics guidelines of The Francis Crick Institute. For mouse blastocysts, embryos
at the two-cell stage were flushed out from the oviducts of C57BL6 × CBA F1
female mice that had been mated to C57BL6 × CBA F1 males. The embryos were
cultured in vitro in KSOM (Millipore) until 3–4 days post fertilisation. All animal
research was performed in compliance with the UK Home Office Licence Number
70/8560.
hESC and iPSC culture. For culture in knockout serum replacement (KSR)
medium supplemented with FGF2 (KSR+ FGF2), cells were maintained on
mitotically inactivated MEF-coated pre-gelatinised tissue culture plates (Corning)
in 20% KSR and 5 ng/ml of FGF2 (R&D). Cells were passaged by manual picking.
For culture in mTeSR1 medium (StemCell Technologies), cells were generally
maintained on Matrigel-coated (BD Biosciences) tissue culture plates. Matrigel
coating was performed for one hour at room temperature (RT) per the
manufacturer’s instructions. Cells were passaged as clumps using ReLeSR (Stemcell
Technologies). ReLeSR was added to wells for 30 s at RT then aspirated, then plates
were incubated for 5 min at 37 °C, quenched with mTeSR1 and lightly tapped to
dislodge clumps of the desired size. Cells were also adapted to plates coated with
0.5 μg/cm2 laminin-511 (Biolamina LN-511, Takara iMatrix-511 T303). Laminin
coating was performed either overnight at 4 °C or for one hour at 37 °C per
manufacturer’s instructions. Cells on laminin-511 were also passaged with ReLeSR
with a 7-min incubation at 37 °C, or dissociated to single-cell level with Accumax
(Fisher Scientific), with a 10-min incubation at 37 °C.
For culture in TeSR-E8 medium (StemCell Technologies), cells were maintained
on vitronectin-coated (StemCell Technologies) tissue culture plates. Vitronectin
coating was performed for 2 h at RT per manufacturer’s instructions. Cells were
passaged as clumps using 0.5 mM EDTA. EDTA was added to wells for 5 min at
RT then aspirated, then TeSR-E8 added to wells and cells disaggregated with a 5 ml
stripette.
For culture in AI medium, cells were maintained on plates coated with 0.5 μg/
cm2 laminin-511. AI medium is made up as follows: first, make basal medium by
combining 490 ml Advanced DMEM/F12 (Life Technologies 12634-010) or
Essential 6 (ThermoFisher A1516401); 5 mL Penicillin Streptomycin (Gibco,
15140-122) and 5 mL GlutaMax (Life Technologies, 35050-038) and filter through
a 0.22 μm bottle-top vacuum filter system. Basal media can be stored for up to one
month in 4 °C. To make complete medium, add 50 ng/ml recombinant Human/
Murine/Rat Activin A (Qkine, Qk001 or Peprotech, 120-14) and 17 nM IGF1 (291-
G1/CF, R&D) to basal medium. Once growth factors are added, use media within
1 week. IGF1 was reconstituted to 200 μg/ml in sterile 1x Ca+/Mg+-free PBS.
Activin A was reconstituted to 500 μg/ml in embryo culture grade water.
Reconstituted growth factors were aliquoted and stored at −80 °C to minimise
freeze-thaw cycles before use.
Early passage newly derived hESCs in AI medium were passaged by manual
picking. Established cells in AI medium were also split using various dissociation
reagents. For ReLeSR, cells were passaged similar to cells in mTeSR1 on laminin-511.
For Accutase (StemCell Technologies) or Accumax, dissociation reagent was added to
wells for 5–10min, the well contents were collected and pelleted, and the dissociation
reagent removed. Cells were resuspended in AI medium with or without 10 μm
ROCK inhibitor (Y27632, Tocris) for plating. For Gentle Cell Dissociation Reagent
(StemCell Technologies), reagent was added to wells for 6 min, then aspirated and AI
medium added. Well contents were collected and disaggregated with a 5ml stripette.
For 0.5mM EDTA (Sigma), reagent was added for 5min then aspirated, AI medium
added and cells disaggregated. For Ca+/Mg+-free PBS (Gibco, Life Technologies),
reagent was added for 6min, aspirated, then AI medium added and cells
disaggregated.
For inhibitor treatment experiments, culture medium was supplemented with
100 nM PD173074 (FGFR tyrosine kinase inhibitor), 1 μm PD0325901 (MEK
inhibitor), 10 or 1 μm OSI-906 (IGF1R/IR inhibitor), 100 nM GDC-9041 (PI3K
inhibitor), 50 nM Everolimus (mTOR1 inhibitor), 1 mM CHIR99021 (GSK3β
inhibitor) or 10 μm SB-431542 (Activin/Nodal receptor inhibitor). Cells were
exposed to inhibitors for 24 h for western blot and 72 h for proliferation assays.
Fig. 4 IGF1 treatment of human embryos promotes ICM proliferation. a Representative western blots for selected proteins related to MAPK/PI3K/AKT/
mTOR signalling in mouse and human embryos. n= 6 human blastocysts at 6 days post fertilisation (dpf) per experiment, and 5 or 10 mouse blastocysts.
Given the limited human material, after WB transfer the higher and lower molecular weight regions of the blot were cut and probed separately. The cut
junction can be seen in the upper edge of pS6. Full-length western blots are shown in Supplementary Fig. 11. Data represents n= 5 replicate experiments.
b Schematic of human embryo treatment schedule. c Immunofluorescence analysis for NANOG (EPI, green) and SOX17 (PE, red) with DAPI (blue) nuclear
stain at 6.5 dpf in control embryos or embryos treated with 17 nM IGF1 from 2 dpf. Scale bar: 100 μm. d Immunofluorescence analysis for NANOG (green),
KLF17 (red) and DAPI (blue) at 6.5 dpf following 17 nM IGF1 treatment from 2 dpf. Scale bar: 100 μm. e Quantification of total cell number (DAPI stained
nuclei) and percentages of NANOG- or SOX17-expressing cells, and ICM (combined NANOG and SOX17 totals) in control or 17 nM IGF1-treated embryos.
Data points represent the percentage per individual embryo; horizontal line indicates the mean. n= 5 control, 4 treated embryos. One-tailed t-test. *P <
0.05, **P < 0.01. f Immunofluorescence analysis for NANOG (red) and GATA6 (PE, green), with DAPI (blue) at 6.5 dpf in control embryos or embryos
treated with 1 µg/ml FGF2 and 1 µg/ml heparin, or 100 ng/ml FGF2 from 2 dpf. Scale bar: 100 μm. g Immunofluorescence analysis for NANOG (green) and
SOX17 (red) with DAPI (blue) nuclear stain at 6.5 dpf in control embryos or embryos treated with 100 ng/ml FGF2 from 5 dpf. h Quantification of total cell
number (DAPI) and percentages of NANOG- or SOX17-expressing cells, and ICM in control embryos or embryos treated with 100 ng/ml FGF2 from 5 dpf.
Data points represent the percentage per individual embryo; horizontal line indicates the mean. n= 10 control, 9 treated embryos. One-tailed t-test. *P <
0.05, **P < 0.01. Source data are provided as a Source Data file.
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Naïve hESCs were cultured in t2iL+Gö39 and maintained on mitotically
inactivated MEF-coated pre-gelatinised tissue culture plates (Corning).
Experiments were performed following one passage onto Geltrex (ThermoFisher,
A1413301) coated tissue culture plates. Cells were passaged using Accutase. The
dissociation reagent was added to wells for 5–10 min, the well contents were
collected and pelleted, and the dissociation reagent removed. Cells were
resuspended in t2iL+Gö medium with 10 μm ROCK inhibitor (Y27632, Tocris)
for plating and ROCK inhibitor was subsequently removed for culture and during
experiments.
Immunofluorescence. Embryos were fixed with 4% (w/v) paraformaldehyde
(PFA) (ThermoFisher) for 1 h at 4 °C on a rotating shaker, then transferred
through several washes of 0.1% (v/v) Tween-20 (Sigma) in Ca+/Mg+-free Dul-
becco’s Phosphate-Buffer saline (PBS) without calcium and magnesium (Ther-
moFisher) to remove residual PFA. Embryos were permeabilised in PBS 0.5%
Tween-20 for 20 min, then transferred to blocking solution (10% (v/v) donkey
serum (Sigma) in PBS 0.1% Tween-20) for 1 h at RT. Embryos were placed in
primary antibodies (Supplementary Table 1) at a 1:500 dilution in blocking solu-
tion overnight at 4 °C on a rotating shaker. Embryos were then transferred through
four washes of PBS 0.1% Tween-20 followed by a final 30 min wash. Embryos were
placed in secondary antibodies (Supplementary Table 2) at a 1:300 dilution in
blocking solution for 1 hour at RT on a rotating shaker, then transferred through
four washes of PBS 0.1% Tween-20 and a final 30 min wash. Embryos were placed
in a 50 μL 1:30 dilution of DAPI-containing Vectashield (Vector Labs) in PBS 0.1%
Tween-20 on a coverslip bottom dish (MatTek) for confocal imaging.
hESCs, iPSCs and differentiated cells were subjected to a similar protocol.
Briefly, cells were washed twice with Ca+/Mg+-free PBS and fixed with 4% (PFA)
for 1 h. Cells were then permeabilised with PBS 0.5% (v/v) Triton X-100 (Sigma) or
PBS 0.5% Tween-20, then transferred to blocking solution (2–10% donkey serum
in PBS 0.05% or 0.01% Tween-20), before overnight incubation at 4 °C with
primary antibodies. Cells were washed three times with PBS 0.05% or 0.01%
Tween-20, then secondary antibodies diluted at 1:300 in blocking solution were
added for 1 hour at RT. Cells were washed several times in PBS 0.1% Tween-20 and
placed in a final wash for 30 min. A drop of DAPI-containing Vectashield was
added to each well prior to imaging.
Primary and secondary antibodies are listed in Supplementary Tables 1 and 2,
respectively.
Embryo confocal imaging and immunofluorescence quantification. Embryos
were imaged on a Leica SP5 inverted confocal microscope (Leica Microsystems
GmbH) at a z-section thickness of 3 μm. Confocal stacks in TIFF format were
loaded into the MINS 1.3 software automated pipeline to detect and segment nuclei
and determine the number of cells in each embryo (http://katlab-tools.org/)72. The
MINS segmentation output was manually checked for appropriate segmentation
and mitotic nuclei were removed from the analysis.
Imaging of cell lines. Images were acquired using a Leica TCS SP8 confocal
microscope or an Olympus 1 × 73 microscope with Cell^F software (Olympus
Corporation). Phase-contrast images were taken on a Leica DM IL LED micro-
scope with a Leica MC170 H9 camera (Leica Microsystems GmbH).
hESC derivation from preimplantation embryos. Human blastocysts at 5 or
6 days post fertilisation (dpf) were initially cultured in Global Media (LifeGlobal)
supplemented with 5 mg/mL LifeGlobal Protein Supplement pre-equilibrated in an
incubator at 37 °C and 5% CO2 prior to stem cell derivation. Embryos at 6 dpf
were microdissected to isolate the ICM using an Olympus IX73 microscope and a
Saturn 5 laser (Research Instruments), as described previously89. Embryos were
placed in drops of Global® Total® w/HEPES (LGTH, LifeGlobal) on a Petri dish
overlaid with mineral oil for micromanipulation. The ICM and polar trophecto-
derm were plated onto mitotically inactivated MEF-coated dishes in AI medium.
ICM outgrowths with hESC-like morphology were manually picked onto laminin-
511 coated dishes for further propagation. Three independent hESC lines were
established: CH1, CH2 and CH3.
Human iPSC derivation. Human BJ fibroblast cells (ATCC ® CRL-2522) were
plated so as to be 30–60% confluent for transduction two days later (1 × 105 cells
per well of a six-well plate). Cells were transduced using the Cytotune™ 2.0 Sendai
reprogramming kit (Invitrogen) per manufacturer’s instructions, and transferred
6 days after transduction to dishes coated with either MEFs (KSR+ FGF2 med-
ium), vitronectin (TeSR™-E8 medium) or laminin-511 (AI medium). At this point
cells were transferred to hypoxia conditions (5% O2, 5% CO2, 37 °C) for the
remainder of the derivation. TRA-1-60 expression was analysed 18 days after
transduction using the Stemgent® StainAlive™ TRA-1-60 Antibody (DyLight™ 488)
kit, per manufacturer’s instructions (1:100 dilution). Colonies with pluripotent ES
cell morphology were picked 22 days after transduction for expansion to establish
stable iPSC lines. Alkaline phosphatase staining was carried out using an Alkaline
Phosphatase Detection Kit (SCR004, Millipore) as per manufacturer’s instructions.
Human MRC5 cells (ECACC 05072101) were routinely cultured in DMEM
(Sigma D6546) supplemented with 10% FBS (Sigma, F7524) and 2 mM Glutamax
(Gibco®). Cells were plated on laminin-511 at 1 × 105 cells per well of a six-well
plate one day prior to reprogramming in MRC5 media. On the day of
reprogramming media was changed to AI medium or Nutristem hPSC XF culture
medium (Stemgent 01-0005). Cells were reprogrammed over 4 days using the
Stemgent® StemRNA™ 3rd Gen Reprogramming Kit for Reprogramming Adult and
Neonatal Human Fibroblasts (Reprocell, 00-0076) as per manufacturer’s
instructions. Cells were maintained under the following incubator conditions: 5%
O2, 5% CO2, 37 °C. From day 5 onwards, daily complete media changes were
performed with either AI or Nutristem media. Live-cell staining with alkaline
phosphatase (ThermoFisher, A14353) was performed as per manufacturer’s
instructions on day 34following the first of four transfections.
Cell proliferation assay. Cells cultured in AI, mTeSR1, KSR+ FGF or t2iL+Gö
medium were plated on day 0 at 2 × 104 cells/cm2. Cell counts were measured every
day thereafter for 3 or 4 days using a Nucleocounter NC-200 (Chemometech) or a
Scepter Automated Cell Counter (Millipore). Population doublings were calculated
according to Equation 1 or cell density was plotted.
PDL ¼ log10
Viable cell number at time t
Viable cell number at time t1
0:30103
Flow cytometry. Expression of surface and intracellular pluripotency-related
proteins was analysed using a MACSQuant® Analyzer10 flow cytometer (Miltenyi
Biotech) or BD LSRFortessa™ flow cytometer (BD Biosciences). Single-cell sus-
pensions were washed and stained in BD Pharmigen™ Stain Buffer (BD Bios-
ciences) with conjugated primary antibodies (Supplementary Table 1). For
intracellular proteins (NANOG, OCT4, SOX2), cells were fixed using BD Cytofix™
fixation buffer (BD Biosciences) and incubated for 15 min at RT. Cells were then
permeabilised with 0.1% Triton X-100 (Sigma) in BD Pharmigen™ Stain Buffer for
15 min at RT prior to staining. Isotype controls were performed for each antibody
(listed in Supplementary Table 3). Cells were stained with Live/Dead® dis-
crimination dye (L23105, ThermoFisher) and phenotype analysis of the live single-
cell population fraction performed by flow cytometry. Isotype staining was con-
sidered as a negative control for each analysis and condition.
hESC targeting in AI media. hESCs were cultured on laminin-511 in AI media
and pre-treated for 16 h with 10 μM Y-27632 (Tocris). hESCs were dissociated to
single cells with Accumax (Thermo Fisher Scientific), with a 10 min incubation at
37 °C. 2 × 106 cells were nucleofected in 100 μl with a total of 4 μg of either the
targeting vector (gRNA targeting ARGFX cloned into pSpCas9(BB)-2A-Puro
[pX459] v2.0) or pMaxGFP (supplied with the kit) using the Lonza P3 Primary Cell
4D-Nucleofector X Kit and the cycle CB 150 on a Lonza 4D-Nucleofector System,
according to the manufacturer’s instructions. Nucleofected hESCs were plated onto
three wells of a six-well plate on a feeder layer of DR4 MEFs (puromycin and
neomycin resistant) and cultured in AI media (without antibiotics) containing
10 μM Y-27632. After 30 h of culture the cells were selected in AI media containing
0.5 μg/ml of puromycin for 48 h. Following selection, the colonies were allowed to
grow for 10 days, after which DNA was isolated from one well of the 6-well plate
and subjected to the T7 endonuclease I assay to assess targeting efficiency as
described in Renouf et al.90. The remaining 2 wells were subjected to alkaline
phosphatase stain as described above.
pSpCas9(BB)-2A-Puro [pX459] v2.0 was a gift from Feng Zhang (Addgene
plasmid#62988)
The gRNA sequence used for ARGFX: CCTACCGGAGTCAACAGTAA.
The primers used for the amplicon PCR are:
Forward primer: GAAGCAATACGGAGAAGGCA
Reverse primer: GGGTAGAGGGTGGGGAATTT
Karyotype by G-banding and whole-genome sequencing. For G-banding kar-
yotype analysis, hESCs and iPSCs were fixed in suspension. Multiple metaphase
spreads were analysed per sample and the number of chromosomes and G-banding
pattern were determined. For whole-genome sequencing a DNeasy Blood & Tissue
kit (Qiagen) was used to isolate genome DNA from hESCs cultured in AI medium.
Isolated DNA was quantified on a Nanodrop prior to library preparation using a
Nextera XT kit (Illumina). Libraries were sequenced paired-end with at least 100 bp
reads on a HiSeq 4000 machine (Illumina).
RNA FISH. RNA FISH was carried out as previously described91 with minor
modifications. Two drops of cell suspension in phosphate-buffered saline were
added on to a slide placed on cold platform and cells were allowed to settle for 3–4
min. Cells were permeabilised with ice-cold 0.5%Triton X-100, 2 mM Vanadyl
Ribonucleoside (Biolabs) in PBS for 10 min and fixed with ice cold 4% paraf-
ormaldehyde (pH 7–7.4) for 10 min. Slides were rinsed in PBS, dehydrated through
an ethanol series (2 × 70%, 80%, 96%, 100%) and air-dried. BAC DNA was labelled
using Nick Translation Direct Labelling Kit (30-608364/R1; Roche) according to
manufacturer’s instructions, and using fluorescent nucleotides spectrum orange
(02N33-050, Vysis)—dUTP for XIST (BAC-RP11-13M9) and spectrum green
(02N32-050, Abbott)—dUTP for ATRX (BAC-RP11-1145J4). Cells were hybridised
with a denatured mix of probes (XIST 0.1 μg probe and ATRX 0.1 μg probe), 3 μg
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-14629-x
12 NATURE COMMUNICATIONS |          (2020) 11:764 | https://doi.org/10.1038/s41467-020-14629-x | www.nature.com/naturecommunications
human COT1 DNA and 10 μg salmon sperm DNA in hybridisation buffer (50%
formamide, 25% dextran sulphate, 5 mg/ml BSA, 1 mM Vanadyl Ribonucleoside
complex in 2X SSC) at 37 °C overnight in a humid chamber. Slides were subjected
to stringency washes at 42 °C, three times for 5 min in 50% formamide, 1X SSC
(pH 7.2–7.4), and three times for 5 min in 2X SSC (pH 7–7.2). Slides were mounted
in antifade with DAPI.
Differentiation assays. For spontaneous differentiation, hESCs cultured in AI
medium were switched into MEF culture medium (10% FBS) for 6 or 12 days, and
cells fixed for immunofluorescence analysis for germ layer lineage markers.
For directed differentiation to hepatocytes, hESCs adapted to AI medium were
taken through a previously described protocol54. hESCs were dissociated to single
cells using Accutase then resuspended in AI medium containing 10 μm ROCK
inhibitor for seeding at 1 × 105/cm2 onto gelatinised tissue culture plates pre-coated
with MEF medium. AI medium was replenished 24 h later. The hepatocyte
differentiation protocol was started 48 h after seeding, and cells were maintained
under hypoxia conditions from then on. Cells were fixed for immunofluorescence
analysis 3 days (endoderm), 8 days (foregut endoderm) and 25 days (mature
hepatocytes) following differentiation induction.
For directed differentiation to cardiomyocytes, hESCs were cultured using the
STEMdiff Cardiomyocyte Differentiation Kit (StemCell Technologies, 05010). Cells
adapted to AI medium were seeded at a density of 1.625 × 106/cm2 onto Matrigel-
coated plates, with 10 μm ROCK inhibitor. AI medium was replenished 24 h later.
From day 2, cells were treated according to the manufacturer’s protocol: two days
with medium A, two days with medium B, and four days with medium C. From 8
to 15 days after differentiation, cells were fed with the provided cardiomyocyte
maintenance medium (replenished every 2 days). RNA samples were collected 8
and 15 days following differentiation induction, and cells fixed for
immunofluorescence at day 15.
For neuronal progenitor cells, hESCs adapted to AI medium were differentiated
using a modification of previously described protocols55,92. Cells adapted to AI
medium were seeded at a density of 1.5 × 106/cm2 onto laminin-coated plates, with
10 μm ROCK inhibitor. AI medium without ROCK inhibitor was replenished 24 h
later. From day 2, confluent cells were treated with N2B27 medium supplemented
with 10 μm SB431542 and 1 μm LDN193189 (Stemgent). On days 7, 12 and 16
following induction, cells were passaged with Accutase for 4 min, cell collected in
N2B27 media, spun down and then plated in either N2B27 medium supplemented
with 10 μm SB431542 and 1 μm LDN193189 (until day 12) or N2B27 media (from
day 12 to 20) for subsequent culture. Cells were fixed for immunofluorescence
analysis 7, 12, 16 and 20 days following differentiation induction.
Quantitative RT-PCR. RNA was isolated using TRI Reagent (Sigma) and DNaseI
treated (Ambion). cDNA was synthesised using a Maxima First Strand cDNA
Synthesis Kit (Fermentas). Quantitative RT-PCR (qRT-PCR) was performed using
Sensimix SYBR Low-Rox kit (Bioline, QT625) on a QuantStudio 5 machine
(ThermoFisher). Primer pairs (listed in Supplementary Table 4) were previously
published93 or designed using Primer3 software.
Western blot. For hESCs and iPSCs, protein was extracted with CelLytic M
reagent (Sigma) supplemented with protease and phosphatase inhibitors (Roche)
and 15–30 μg of hESC or iPSC protein was resolved on 10% SDS-PAGE gels. For
mouse and human embryos, samples were washed three times with Ca+/Mg+-free
PBS and were directly lysed in Laemmli sample buffer at 95 °C for 5 min. Between
2 and 10 embryos were included per sample as indicated, and resolved on 10%
Mini-Protean TGX precast protein gels (BioRad, 4561036).
Resolved protein gels were transferred to a PVDF membrane using a BioRad
Trans-Blot transfer system (BioRad). Membranes were blocked in TBS and 0.1%
Tween (Sigma) with 5–10% skimmed milk, and incubated with primary antibody
at 4 °C overnight. Following washes in TBS 0.1% Tween, membranes were
incubated with secondary antibody for one to 3 h at RT. Proteins were visualised
using the Pierce ECL Western Blotting Substrate (ThermoFisher) using an
Amersham Imager 600. Antibodies are listed in Supplementary Tables 1 and 2.
Full-length western blots are shown in Supplementary Fig. 11.
Single-cell RNA-seq. cDNA was generated from single cells using the SMART-Seq
V4 Ultra Low Input Kit (Clontech 634898) as previously described10. cDNA was
amplified by adding 25 μl 2X SeqAmp PCR buffer, 1 μl PCR Primer II A (12 μM),
1 μl SeqAmp DNA polymerase, 3 μl nuclease-free water, and incubated on a PCR
machine at 95 °C for 1 min, 23 cycles of 98 °C for 10 s, 65 °C for 30 s and 68 °C for
3 min, before a final extension for 10 min at 72 °C. Amplified cDNA was purified
using 50 μl AMPure XP beads (Beckman Coulter) per manufacturer’s instructions.
Sample tubes were mixed well and incubated at RT for 8 min to bind the cDNA to
the beads. Tubes were put on a magnet until the supernatant ran clear so that it
could be removed and discarded. The beads were washed twice with 200 μl 80%
ethanol. Any remaining ethanol was removed and beads allowed to dry, then
resuspended in 12 μl of elution buffer. Tubes were returned to the magnet and the
clear supernatant containing the cDNA was collected in a new tube and stored at
−80 °C until library preparation.
cDNA quality was assessed by High Sensitivity DNA assay on an Agilent 2100
Bioanalyzer, with good quality cDNA showing a broad peak from 300 to 9000 bp.
cDNA concentration was measured using Qubit dsDNA HS kit (Life Technologies).
In preparation for library generation, 10 μl of cDNA sample and 32 μl
purification buffer were added to a Covaris microTUBE AFA Fiber Pre-Slit Snap
Cap. cDNA was sheared to a 200–500 bp range using an E220 focused-
ultrasonicator (Covaris) for 2 min at Peak Incident power 175W, Duty Factor 10%,
200 cycles per burst, water level 5. Libraries were prepared using a Low Input
Library Prep Kit HT (Clontech, 634900) per manufacturer’s instructions. Library
quality and cDNA concentration was assessed by Bioanalyzer and Qubit. For
library purification, 75 μl of AMPure XP beads was added to each collection tube
containing the cDNA and treated as described above.
Analysis of transcriptome datasets. A detailed analysis pipeline can be found at
the following site: https://github.com/galanisl/AI_hESCs.
Single-cell RNA-seq samples generated in this study were compared to
published RNA-seq datasets for hESCs and human embryo EPI, PE and TE
cells10,28,31,33,37,56,58. Read quality control was performed using FastQC v0.11.6
and results integrated with multiqc v0.9. Quality and adapter trimming with Trim
Galore! v0.5.0 were applied to samples that did not pass the quality controls.
Mapping was performed against the human reference transcriptome GRCh38
using the salmon v0.11.3 program94. Transcript IDs were mapped to gene IDs and
official gene symbols using biomaRt v2.36.1. Gene-level summarisation of counts
and combination of all sample data was carried out with tximport v1.8.0.
The tximport list was transformed into a DESeqDataSet with DESeq2 v1.20.095.
Mitochondrial-, ribosomal- and pseudo-genes were removed from the count matrix, as
well as no-show and invariant genes. We normalised the count data by size factor
using DESeq2 to remove the correlation between average counts of a gene across
samples and variance. We then log-transformed the normalised expression matrix
(Supplementary Data 6). In addition, we removed batch effects due to sequencing type
(bulk vs. single-cell) using the limma v3.36.5 program96. Briefly, the function
removeBatchEffect in limma fits a linear model to the data, including batches and the
condition of interest, and then removes the component due to the batch effects. We
imputed drop-out events in the samples sequenced with single-cell RNA-seq via
DrImpute v1.197. To identify highly variable genes (HVGs) for dimensionality
reduction of the size-factor-normalised data, it was assumed that the trend fitted to the
mean-variance curve represented the technical component of the variance, with
expression values that significantly deviate from this reference corresponding to
HVGs98. The functions trendVar() and decomposeVar() from scran v1.8.498 were
applied, which identified 3087 highly variable genes (HVGs) at the significance level
α= 0.01 after Benjamini-Hochberg correction.
Gene expression data was also embedded to three-dimensional space using
UMAP57, a non-linear dimensionality reduction approach. We used k= 30 nearest
neighbours to construct the initial proximity graph for the human embryonic cells
and ESCs and k= 15 when the cynomolgus monkey data was integrated.
The griph tool (https://github.com/ppapasaikas/griph) was used to identify
clusters of transcriptionally similar cell types, accounting for confounding factors
such as the cell cycle stage or batch effects to identify clusters of transcriptionally
similar cell types.
Genes identified as differentially expressed from a DESeq2 analysis were used to
perform a Gene Ontology60 and REACTOME61 functional enrichment analysis.
The FunEnrich package (https://github.com/galanisl/FunEnrich) was used with
focus on the five most enriched GO terms and REACTOME pathways based on
Benjamini-Hochberg corrected p-values.
To integrate the RPM-normalised gene expression matrix from the cynomolgus
monkey samples99 with human ESC and embryo data, we normalised the latter by
RPM and filtered all datasets in order to keep only orthologs between human and
monkey59. Orthology mapping was based on published gene lists99. Furthermore,
we removed no-show genes for dimensionality reduction.
Gene expression analysis. We identified pathways enriched in the Epi versus the
PE and TE, as well as the TE versus the PE using gene set expression analysis38. For
this, we used a compendium of multiple pathway databases compiled by the Bader
Lab at http://download.baderlab.org/EM_Genesets/current_release/Human/
symbol/Pathways/ (01/08/2019 snapshot). Genes were ranked according to log2-
fold changes between each pairwise comparison to generate rank files that were
then used as input for the GSEAPreranked module of the GSEA v3.0 tool. We
scanned the output files with v3.2.0 of the EnrichmentMap app39 in Cytoscape40
v3.7.1 to represent the relationship between enriched signalling pathways using a
significance level of 0.05 for the nominal p-values.
The list of ligands that activate the MAPK signalling pathway was extracted
from the corresponding entry (hsa:04010) on the KEGG pathway database41.
To identify ligand-receptor partners, we manually extracted a list of all ligands
and receptors from all signal transduction pathways of the KEGG database41. We
paired ligands with their corresponding receptors based on protein interaction data
from version 2.2 of the HIPPIE database42. Finally, we calculated the median
expression of ligands and receptors in the epiblast, primitive endoderm and
trophectoderm using RPKM expression values.
We used version 1.22.3 of the R package pathview100 to overlay log2-
transformed median RPKM expression values on all signal transduction pathways
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of the KEGG database41. For pathway members that represent gene categories
instead of a single gene, we used the maximum expression of all the genes falling in
the category. A range 0 to 15 in the log2-transformed RPKM scale was used for the
three embryonic cell types and the window was divided in 20 bins to define colour
intensities for the pathway members.
Shiny app. We used version 1.3.2 of the R package shiny to develop a Shiny App
to facilitate access to the above KEGG pathway diagrams via an interactive web
page. This Shiny App colours pathway members according to their expression
in the three different cell types of the human blastocyst (epiblast, primitive
endoderm and trophectoderm). All the KEGG signal transduction pathways
under the category Environmental Information Processing (see https://www.
genome.jp/kegg/pathway.html#environmental) can be chosen from a dropdown
menu, as well as selecting the cell type based on which the pathway members are
coloured. Gene expression is shown as a colour range between 0 and 15 in log2
(RPKM+ 1) units divided in 20 bins. Since gene expression comes from a
single-cell RNA-seq dataset10,37, pathway members on the KEGG diagram are
coloured with the median expression of the gene across single cells of the same
type. When pathway members represent a gene category instead of a single
gene, the maximum median is represented. Clicking on pathway members
generates boxplots with the expression distribution of the gene or genes in the
three blastocyst cell types.
Analysis of low-pass whole-genome sequencing. We performed quality control
with FastQC v0.11.8 and adapter and quality trimming with Trim Galore! v0.6.0 if
needed. We aligned samples to the UCSC hg19 reference genome using the two-
pass alignment pipeline of STAR v2.7.0d. Copy number analysis of the samples was
performed using the R package QDNAseq v1.18.0. With this package, we divided
the hg19 reference genome into non-overlapping bins of size 1000 kb. Then, we
counted the number of sequence reads per bin and used these counts to estimate
copy numbers. These estimates are normalised and outliers smoothed. Finally, we
performed segmentation and plotted the copy number profile.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The authors declare that all data supporting the findings of this study are available within
the article and its supplementary information files or from the corresponding author
upon reasonable request. RNA-seq FastQ files have been deposited in the Gene
Expression Omnibus repository under accession code GSE126488 and using the IDs
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